Results 161 to 170 of about 20,268 (224)

What Exactly Is Cardiometabolic HFpEF: A Phenotype or an Endotype? [PDF]

Circ Heart Fail
Packer M, Schiattarella GG, Borlaug BA.
europepmc   +1 more source

HFpEF Diagnosis

JACC: Case Reports
openaire   +1 more source

Atrial fibrillation, sinoatrial and atrioventricular node dysfunction in a mouse model of heart failure with preserved ejection fraction

Experimental Physiology, Volume 111, Issue 3, Page 963-977, 1 March 2026.
Summary of the timeline of characterized events related to atrial fibrilation (AF) and diastolic dysfunction in a mouse heart failure with preserved ejection fraction (HFpEF) model. Three weeks after the initiation of the diet regimen with high fat diet (HFD) and Nω‐nitro‐l‐arginine methyl ester (l‐NAME) in drinking water to induce HFpEF, significantly
Bernadin Ndongson‐Dongmo, Reinhard Bauer, Finn Olav Levy   +2 more
wiley   +1 more source

Lymphocyte-To-Monocyte Ratio is Partially Mediated in Age-Related Cardiovascular Mortality in HFpEF: Immunosenescence, Inflamm-Aging, and Longevity. [PDF]

Rev Cardiovasc Med
Cai X, Liu M, Feng C, Tang S, Qin P, Li Y, Wang T, He L, Lei J, Zhou Y, Guo Y, Zhuang X, Liao X.   +12 more
europepmc   +1 more source

EuroSCORE II: Current limitations and physiological gaps in risk stratification

Experimental Physiology, Volume 111, Issue 3, Page 1069-1080, 1 March 2026.
Abstract Risk stratification remains critical in cardiac surgery, enabling clinicians to predict adverse outcomes and guide perioperative management. The European System for Cardiac Operative Risk Evaluation (EuroSCORE) II, introduced in 2011, incorporates 18 key variables to provide an evidence‐based approach to risk assessment.
Jing Yong Ng, Eu Fon Tan, Marsioleda Kemberi, Eduardo Urgesi, Matti Jubouri, Damian M. Bailey, Mohamad Bashir, Wael I. Awad   +7 more
wiley   +1 more source

Insulin resistance with associated hyperinsulinemia as a risk factor for the development and worsening of HFpEF. [PDF]

Front Cardiovasc Med
Fazio S, Carlomagno G.
europepmc   +1 more source

Reduced Exercise Capacity in Breast Cancer Compared to HFpEF: Mechanistic Insights From Invasive Exercise Testing. [PDF]

JACC CardioOncol
Landsteiner I, Foulkes SJ, Campain J, Camphausen CE, Zlotoff DA, Lewis GD, Haykowsky MJ.   +6 more
europepmc   +1 more source

Cancer and the risk of death, heart-failure hospitalization, and major adverse cardiovascular events in HFpEF: a propensity-matched cohort study. [PDF]

Front Oncol
Li C, Meng F, Xie Y, Li P, Jiao J.
europepmc   +1 more source

Does Secondary HFpEF Exist? Yes, but it Should not be Called HFpEF

Arquivos Brasileiros de Cardiologia
Humberto Villacorta, Pedro Schwartzmann
openaire   +2 more sources

Clinical Impact of Febuxostat in HFpEF Versus HFrEF: Insights from a Prospective Cohort. [PDF]

Balkan Med J
Ahsaan F, Latif B, Rehman Z.
europepmc   +1 more source